Yehia Hashad

Yehia Hashad

Chief Tech/Sci/R&D Officer at BAUSCH + LOMB CORPORATION

Net worth: 3 M $ as of 31/05/2026

59 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Yehia Hashad, MD, is a Chief Medical Officer & EVP-Research & Development at Bausch + Lomb Corp., a Senior VP & Global Head-Research & Development at Allergen Aesthetics and a Member-Executive Board at Reeve-Irvine Research Center.
Dr. Hashad was previously employed as a VP & Global Head-Ophthalmology Therapeutic Areas by Allergan, Inc. He also served on the board at Unity Biotechnology, Inc., Applied Genetic Technologies Corp., Glaucoma Research Foundation and National Alliance for Eye & Vision Research.
He received his undergraduate degree from INSEAD.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/05/2026 166,377 ( 0.05% ) 3 M $ 31/05/2026

Yehia Hashad active positions

CompaniesPositionStart
BAUSCH + LOMB CORPORATION Chief Tech/Sci/R&D Officer 31/01/2022
Allergen Aesthetics
Chief Tech/Sci/R&D Officer 01/05/2020
Reeve-Irvine Research Center
Corporate Officer/Principal -

Former positions of Yehia Hashad

CompaniesPositionEnd
UNITY BIOTECHNOLOGY, INC. Director/Board Member 27/06/2025
APPLIED GENETIC TECHNOLOGIES CORPORATION Director/Board Member 01/12/2022
ALLERGAN, INC. Corporate Officer/Principal 01/04/2019
National Alliance for Eye & Vision Research
Director/Board Member -
Director/Board Member -
See the detail of Yehia Hashad's experience

Training of Yehia Hashad

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

National Alliance for Eye & Vision Research

Commercial Services

Health Technology

Reeve-Irvine Research Center

Health Technology

Allergen Aesthetics